Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543659

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1543659

Global Syphilis Immunoassay Diagnostics Market Size Study, by Product Type (Analyzers, Kits and Reagents), by Technology (CLIA, ELISA), by End User (Blood Banks, Diagnostic Labs, Hospitals) and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Syphilis Immunoassay Diagnostics Market was valued at approximately USD 337.97 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.5% over the forecast period from 2024 to 2032. Syphilis, a significant bacterial infection impacting both men and women, requires meticulous clinical suspicion and routine screening, particularly among high-risk patients, making laboratory testing indispensable for diagnosis. Recent advancements in faster, automated treponemal testing have revolutionized syphilis screening strategies, enhancing diagnostic efficiency.

The market growth is driven by various socioeconomic factors, including the rising prevalence of sexually transmitted diseases (STDs) and an increase in sexual activities influenced by substances like heroin, cocaine, methamphetamine, cannabis, benzodiazepines, and alcohol. Additionally, the alarming rise in fatal syphilis infections, increased availability of testing facilities, technological advancements in testing, and the advent of on-the-spot testing significantly contribute to the market expansion. According to the World Health Organization (WHO), in 2020, there were approximately 374 million new infections involving chlamydia, gonorrhea, syphilis, and trichomoniasis, underscoring the critical need for advanced diagnostic solutions. However, market growth is hampered by a lack of awareness in emerging economies. Despite this, the untapped potential in these regions and continuous advancements in the Syphilis Immunoassay Diagnostics industry offer substantial growth opportunities. The comprehensive market evaluation encompasses an analysis of key segments, trends, drivers, restraints, and competitive dynamics that play a pivotal role in the market's trajectory.

In 2023, North America emerged as the dominant region, buoyed by a high prevalence of syphilis, an increase in market players, and a surge in testing facilities. The Asia-Pacific region is anticipated to witness the highest CAGR during the forecast period, driven by the large populations in countries like India and China, which contribute to higher STD prevalence rates and dynamic market strategies adopted by key players.

Major market players included in this report are:

  • BioMerieux SA
  • Becton Dickinson & Company
  • Shenzhen New Industries Biomedical Engineering Co. Ltd
  • Fujirebio
  • Siemens Healthineers AG
  • BioRad Laboratories Inc
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation
  • Diasorin S.P.A

The detailed segments and sub-segments of the market are explained below:

By Product Type:

  • Analyzers
  • Kits and Reagents

By Technology:

  • CLIA
  • ELISA

By End User:

  • Blood Banks
  • Diagnostic Labs
  • Hospitals

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Syphilis Immunoassay Diagnostics Market Executive Summary

  • 1.1. Global Syphilis Immunoassay Diagnostics Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By Technology
    • 1.3.3. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Syphilis Immunoassay Diagnostics Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Syphilis Immunoassay Diagnostics Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rise in Socioeconomic Factors
    • 3.1.2. Surge in Testing Facilities and Technology
  • 3.2. Market Challenges
    • 3.2.1. Lack of Awareness in Emerging Economies
  • 3.3. Market Opportunities
    • 3.3.1. High Growth Potential in Untapped Economies
    • 3.3.2. Technological Advancements in Diagnostics

Chapter 4. Global Syphilis Immunoassay Diagnostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Syphilis Immunoassay Diagnostics Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Syphilis Immunoassay Diagnostics Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 5.2.1. Analyzers
    • 5.2.2. Kits and Reagents

Chapter 6. Global Syphilis Immunoassay Diagnostics Market Size & Forecasts by Technology 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Syphilis Immunoassay Diagnostics Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 6.2.1. CLIA
    • 6.2.2. ELISA

Chapter 7. Global Syphilis Immunoassay Diagnostics Market Size & Forecasts by End User 2022-2032

  • 7.1. Segment Dashboard
  • 7.2. Global Syphilis Immunoassay Diagnostics Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 7.2.1. Blood Banks
    • 7.2.2. Diagnostic Labs
    • 7.2.3. Hospitals

Chapter 8. Global Syphilis Immunoassay Diagnostics Market Size & Forecasts by Region 2022-2032

  • 8.1. North America Syphilis Immunoassay Diagnostics Market
    • 8.1.1. U.S. Syphilis Immunoassay Diagnostics Market
      • 8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 8.1.1.2. Technology breakdown size & forecasts, 2022-2032
      • 8.1.1.3. End User breakdown size & forecasts, 2022-2032
    • 8.1.2. Canada Syphilis Immunoassay Diagnostics Market
  • 8.2. Europe Syphilis Immunoassay Diagnostics Market
    • 8.2.1. U.K. Syphilis Immunoassay Diagnostics Market
    • 8.2.2. Germany Syphilis Immunoassay Diagnostics Market
    • 8.2.3. France Syphilis Immunoassay Diagnostics Market
    • 8.2.4. Spain Syphilis Immunoassay Diagnostics Market
    • 8.2.5. Italy Syphilis Immunoassay Diagnostics Market
    • 8.2.6. Rest of Europe Syphilis Immunoassay Diagnostics Market
  • 8.3. Asia-Pacific Syphilis Immunoassay Diagnostics Market
    • 8.3.1. China Syphilis Immunoassay Diagnostics Market
    • 8.3.2. India Syphilis Immunoassay Diagnostics Market
    • 8.3.3. Japan Syphilis Immunoassay Diagnostics Market
    • 8.3.4. Australia Syphilis Immunoassay Diagnostics Market
    • 8.3.5. South Korea Syphilis Immunoassay Diagnostics Market
    • 8.3.6. Rest of Asia Pacific Syphilis Immunoassay Diagnostics Market
  • 8.4. Latin America Syphilis Immunoassay Diagnostics Market
    • 8.4.1. Brazil Syphilis Immunoassay Diagnostics Market
    • 8.4.2. Mexico Syphilis Immunoassay Diagnostics Market
    • 8.4.3. Rest of Latin America Syphilis Immunoassay Diagnostics Market
  • 8.5. Middle East & Africa Syphilis Immunoassay Diagnostics Market
    • 8.5.1. Saudi Arabia Syphilis Immunoassay Diagnostics Market
    • 8.5.2. South Africa Syphilis Immunoassay Diagnostics Market
    • 8.5.3. Rest of Middle East & Africa Syphilis Immunoassay Diagnostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. BioMerieux SA
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Market Strategies
    • 9.3.2. Becton Dickinson & Company
    • 9.3.3. Shenzhen New Industries Biomedical Engineering Co. Ltd
    • 9.3.4. Fujirebio
    • 9.3.5. Siemens Healthineers AG
    • 9.3.6. BioRad Laboratories Inc
    • 9.3.7. F. Hoffmann-La Roche AG
    • 9.3.8. Abbott Laboratories
    • 9.3.9. Danaher Corporation
    • 9.3.10. Diasorin S.P.A

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!